JP2023519501A5 - - Google Patents
Info
- Publication number
- JP2023519501A5 JP2023519501A5 JP2022552307A JP2022552307A JP2023519501A5 JP 2023519501 A5 JP2023519501 A5 JP 2023519501A5 JP 2022552307 A JP2022552307 A JP 2022552307A JP 2022552307 A JP2022552307 A JP 2022552307A JP 2023519501 A5 JP2023519501 A5 JP 2023519501A5
- Authority
- JP
- Japan
- Prior art keywords
- oligomer compound
- pharmaceutical composition
- weeks
- composition according
- once
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025266910A JP2026048915A (ja) | 2020-03-13 | 2025-12-19 | プレカリクレイン関連の状態を治療及び予防するための組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062989427P | 2020-03-13 | 2020-03-13 | |
| US62/989,427 | 2020-03-13 | ||
| PCT/US2021/022069 WO2021183857A1 (en) | 2020-03-13 | 2021-03-12 | Compositions and methods for treating and preventing prekallikrein-associated conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025266910A Division JP2026048915A (ja) | 2020-03-13 | 2025-12-19 | プレカリクレイン関連の状態を治療及び予防するための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023519501A JP2023519501A (ja) | 2023-05-11 |
| JP2023519501A5 true JP2023519501A5 (https=) | 2024-03-26 |
| JP7795467B2 JP7795467B2 (ja) | 2026-01-07 |
Family
ID=77672313
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552307A Active JP7795467B2 (ja) | 2020-03-13 | 2021-03-12 | プレカリクレイン関連の状態を治療及び予防するための組成物及び方法 |
| JP2025266910A Pending JP2026048915A (ja) | 2020-03-13 | 2025-12-19 | プレカリクレイン関連の状態を治療及び予防するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025266910A Pending JP2026048915A (ja) | 2020-03-13 | 2025-12-19 | プレカリクレイン関連の状態を治療及び予防するための組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230149438A1 (https=) |
| EP (1) | EP4118208A4 (https=) |
| JP (2) | JP7795467B2 (https=) |
| KR (1) | KR20220152569A (https=) |
| CN (1) | CN115244179A (https=) |
| BR (1) | BR112022016167A2 (https=) |
| IL (1) | IL295631A (https=) |
| MX (1) | MX2022011205A (https=) |
| WO (1) | WO2021183857A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102365486B1 (ko) | 2013-08-28 | 2022-02-18 | 아이오니스 파마수티컬즈, 인코포레이티드 | 프리칼리크레인 (pkk) 발현의 조절 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102365486B1 (ko) * | 2013-08-28 | 2022-02-18 | 아이오니스 파마수티컬즈, 인코포레이티드 | 프리칼리크레인 (pkk) 발현의 조절 |
| HUE052709T2 (hu) * | 2014-05-01 | 2021-05-28 | Ionis Pharmaceuticals Inc | Módosított antiszensz oligonukleotidok konjugátumai és azok alkalmazása PKK expressziójának módosítására |
| ES2982752T3 (es) * | 2015-10-22 | 2024-10-17 | Iltoo Pharma | Composiciones farmacéuticas de il-2 |
| PL4119569T3 (pl) * | 2015-11-06 | 2024-11-18 | Ionis Pharmaceuticals, Inc. | Sprzężone związki antysensowne do zastosowania w terapii |
| TW201828952A (zh) * | 2017-02-08 | 2018-08-16 | 美商Ionis製藥公司 | 調節血管舒緩素b1(klkb1)用於治療頭痛 |
-
2021
- 2021-03-12 WO PCT/US2021/022069 patent/WO2021183857A1/en not_active Ceased
- 2021-03-12 KR KR1020227035309A patent/KR20220152569A/ko active Pending
- 2021-03-12 IL IL295631A patent/IL295631A/en unknown
- 2021-03-12 US US17/908,773 patent/US20230149438A1/en active Pending
- 2021-03-12 EP EP21768905.8A patent/EP4118208A4/en active Pending
- 2021-03-12 JP JP2022552307A patent/JP7795467B2/ja active Active
- 2021-03-12 CN CN202180020558.4A patent/CN115244179A/zh active Pending
- 2021-03-12 BR BR112022016167A patent/BR112022016167A2/pt unknown
- 2021-03-12 MX MX2022011205A patent/MX2022011205A/es unknown
-
2025
- 2025-12-19 JP JP2025266910A patent/JP2026048915A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013533858A5 (https=) | ||
| CN105311029A (zh) | 抗肿瘤活性的喹啉衍生物 | |
| Maspero et al. | Long-term safety of dupilumab in patients with moderate-to-severe asthma: TRAVERSE continuation study | |
| JP2022533981A5 (https=) | ||
| CN112638378A (zh) | 用于根除幽门螺杆菌的组合物 | |
| JP7639156B2 (ja) | チルゼパチド治療方法 | |
| JP2024524984A (ja) | 閉塞性睡眠時無呼吸を治療する方法 | |
| KR20230038644A (ko) | 코로나바이러스 치료를 위한 피르페니돈 | |
| JP2023519501A5 (https=) | ||
| TW202444371A (zh) | 嚴重發熱伴血小板減少症候群病毒感染症之治療劑 | |
| Harfouch et al. | Therapeutic approaches for COVID 19: Challenges and successes | |
| JP2017508737A5 (https=) | ||
| US20250332136A1 (en) | Composition and methods for treatment or prophylaxis of coronavirus and cancers | |
| US8198293B2 (en) | Oxymatrine compositions and related methods for treating and preventing chronic infectious diseases | |
| CN114272254B (zh) | 甘草次酸和芍药苷的组合在治疗肝损伤、肝纤维化中的应用 | |
| JP2024506041A (ja) | 潰瘍性大腸炎を予防、処置、または改善するためのアミセリモド | |
| JP2025522146A5 (https=) | ||
| US20230270724A1 (en) | PDE3 inhibitors for treating viral infections | |
| US6194460B1 (en) | Composition for treating cough induced by angiotensin converting enzyme inhibitors | |
| CN115969828B (zh) | 替拉曲可在制备预防和/或治疗黄热病毒感染的药物中的应用 | |
| EP2307018B1 (en) | Oxymatrine compositions and use thereof for treating and preventing chronic infectious diseases | |
| CN117503763A (zh) | 巴马汀在治疗高血压中的应用 | |
| HK40094222A (zh) | 预防、治疗或改善溃疡性结肠炎的阿米莫德 | |
| TW200824697A (en) | Use of ATP in controlled regional reperfusion as treatment during acute myocardial infarction | |
| CN114569618A (zh) | 一种头孢克洛的复方制剂及制备方法 |